Group G streptococcus에 의한 독소충격증후군 1례
A Case of Group G Streptococcal Toxic Shock Syndrome
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Toxic shock syndrome is an acute, multi-systemic, toxin-mediated illness caused by toxin-producing strains of Staphylococcus aureus and Streptococcus species. Streptococcal toxic shock syndrome is usually caused by Streptococcus pyogenes but Group G streptococcal toxic shock syndrome is rare. Herein, we report a case of group G streptococcal toxic shock syndrome that was successfully treated with toxin reducing antibiotics and intravenous immunoglobulin therapies.
Abstract
Toxic shock syndrome is an acute, multi-systemic, toxin-mediated illness caused by toxin-producing strains of Staphylococcus aureus and Streptococcus species. Streptococcal toxic shock syndrome is usually caused by Streptococcus pyogenes but Group G streptococcal toxic shock syndrome is rare. Herein, we report a case of group G streptococcal toxic shock syndrome that was successfully treated with toxin reducing antibiotics and intravenous immunoglobulin therapies.
참고문헌 (16)
- Lappin E, "Gram-positive toxic shock syndromes", Lancet Infect Dis, 9, pp.281~290 (2009)
- Stevens DL, "The toxic shock syndromes", Infect Dis Clin North Am, 10, pp.727~746 (1996)
- Cone LA, "Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes", N Engl J Med, 317, pp.146~149 (1987)
- Bisno AL, "Streptococcus pyogenes in Priniciples and practice of Infectious diseases", pp.2373~ (2005), Elsevier Inc.
- Wagner JG, "Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review", Clin Infect Dis, 23, pp.1159~1161 (1996)
- Kugi M, "Toxic shock-like syndrome caused by group G Streptococcus", J Infect, 37, pp.308~309 (1998)
- Horii T, "Acute peritonitis and salpingitis associated with streptococcal toxic shock syndrome caused by Lancefield group G alphahaemolytic Streptococcus dysgalactiae subsp. equisimilis", J Med Microbiol, 55, pp.953~956 (2006)
- The Working Group on Severe Streptococcal Infections, "Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition", JAMA, 269, pp.390~391 (1993)
- Sendi P, "Invasive group B Streptococcal disease in non-pregnant adults : a review with emphasis on skin and soft-tissue infections", Infection, 36, pp.100~111 (2008)
- Hashikawa S, "Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome", J Clin Microbiol, 42, pp.186~192 (2004)
- Cunningham MW, "Pathogenesis of group A streptococcal infections", Clin Microbiol Rev, 13, pp.470~511 (2000)
- Tan JS, "Streptococcus species in Antimicrobial therapy and vaccines", pp.736~ (2002), Apple tree productions, LLC
- Zimbelman J, "Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection", Pediatr Infect Dis J, 18, pp.1096~1100 (1999)
- Mascini EM, "Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci", Int J Antimicrob Agents, 18, pp.395~398 (2001)
- Norrby-Teglund A, "Novel therapies in streptococcal toxic shock syndrome: attenuation of virulence factor expression and modulation of the host response", Curr Opin Infect Dis, 11, pp.285~291 (1998)
- Darenberg J, "Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial", Clin Infect Dis, 37, pp.333~340 (2003)